Vaxil Bio Ltd. (TSXV:VXL)
0.160
+0.020 (14.29%)
At close: Mar 6, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 637.44 thousand as of March 9, 2026. Its market cap has decreased by -76.73% in one year.
Market Cap
637.44K
Enterprise Value
190.44K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 637.44K, an increase of 554.75%. That is a compound annual growth rate of 20.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Waverley Pharma | 810.00K |
| ChitogenX | 415.65K |
| Albert Labs International | 372.07K |
| WPD Pharmaceuticals | 324.76K |
| Entheon Biomedical | 1.39M |
| Universal Ibogaine | 1.56M |
| NanoSphere Health Sciences | 205.50K |
| Algernon Health | 2.17M |